interfacebiologics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Sitemap is also available on /sitemap.xml Sitemap: https://www.rippletherapeutics.com/sitemap.xml User-agent: | ||
Meta Tags
| Title | Ripple |
| Description | Keeping Patients in The Ripple Therapeutics’ Epidel technology is founded on a discovery that drugs can be engineered into controlled release Pharmaceuticals and Medical Device Coatings without the use of polymers or excipients. Our lead product (IBE-814 IVT) is a |
| Keywords | Ripple Therapeutics, Epidel, intravitreal implants, microparticles, nanoparticles, medical device coatings, proprietary prodrug, new chemical entity |
Server Information
| WebSite | |
| Host IP | 107.21.8.129 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
interfacebiologics.com Valuation
|
US$868
Last updated: 2023-05-18 02:28:06
interfacebiologics.com has Semrush global rank of 0. interfacebiologics.com has an estimated worth of US$ 868, based on its estimated Ads revenue. interfacebiologics.com receives approximately 100 unique visitors each day. Its web server is located in United States, with IP address 107.21.8.129. According to SiteAdvisor, interfacebiologics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$868 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$24 |
| Yearly Ads Revenue | US$288 |
| Daily Unique Visitors | 6 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| interfacebiologics.com. | A | 3599 | IP: 107.21.8.129 |
| interfacebiologics.com. | NS | 3600 | NS Record: ns54.domaincontrol.com. |
| interfacebiologics.com. | NS | 3600 | NS Record: ns53.domaincontrol.com. |
| interfacebiologics.com. | MX | 3600 | MX Record: 10 interfacebiologics-com.mail.protection.outlook.com. |
| interfacebiologics.com. | TXT | 3600 | TXT Record: hes=27e3608cc18aa73f69cd23e38739d34e6KiMiYU7+CIKHwkFgVKPewbiIiSh6dX8dHiuh2SKreQgKxtn3p+tLijPgY/FE5B9TVGn87mU3eHYd1uDD f6c3g== |
| interfacebiologics.com. | TXT | 3600 | TXT Record: v=spf1 a:mail.interfacebiologics.com a:owa.interfacebiologics.com mx include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-18 02:28:06
| Our Science About News Careers Contact Get in touch (416) 673-8170 busdev@rippletherapeutics.com Keeping Patients in Sight We see new ways to deliver drugs Ripple is a clinical stage ophthalmic therapeutics company focused on sustained drug delivery without the use of polymers or excipients. Our novel therapeutics provide for better outcomes for patients, easier management of care for physicians and lower costs for payors. Ripple’s Discovery Epidel™ is founded on a discovery that drugs can be designed to deliver themselves without the need for polymers or excipients. Epidel™ prodrug materials are readily manufactured into implantable forms like cylinders and microspheres. Drug dissolves from the surface of the implant via surface erosion in a highly predictable manner: dose is dictated by implant surface area; duration by implant diameter. The result is an ability to finely tune pharmacokinetics to meet the needs of a target indication with precision control of drug dosing without the |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx/1.16.1 Date: Sat, 07 May 2022 04:02:51 GMT Content-Type: text/html Content-Length: 169 Connection: keep-alive Location: https://www.interfacebiologics.com/ HTTP/1.1 200 Server: nginx/1.16.1 Date: Sat, 07 May 2022 04:02:51 GMT Content-Type: text/html;charset=UTF-8 Content-Length: 24070 Connection: keep-alive Set-Cookie: AWSALB=xO/F3lUoN0wlocYHa/xHCM47Wnu49WOs/L7AKEQvmiYHJNR7yh4cFGaNxQAbpzw3zTZIv4xl6WDiNt205gXTeTNqcabf8o8iZ5V0gLYs2VtK97lTeJrW9UuAYojE; Expires=Sat, 14 May 2022 08:59:32 GMT; Path=/ Set-Cookie: AWSALBCORS=xO/F3lUoN0wlocYHa/xHCM47Wnu49WOs/L7AKEQvmiYHJNR7yh4cFGaNxQAbpzw3zTZIv4xl6WDiNt205gXTeTNqcabf8o8iZ5V0gLYs2VtK97lTeJrW9UuAYojE; Expires=Sat, 14 May 2022 08:59:32 GMT; Path=/; SameSite=None FF-Cache: c300|dc21/01/30:10/35/16|h170096|i3565 ETag: ID3565 Last-Modified: Sat, 30 Jan 2021 15:35:16 GMT FF-Version: 5.4.20 FF-CacheControl: 0,ff-cache,ff-c-3-0-0|no-cache,no-store,max-age=0 Cache-Control: no-cache,no-store,max-age=0 Strict-Transport-Security: max-age=31536000; includeSubdomains FF-PID: 200_7EBF2FC51FA795C0783FC1099E51B5B6 FF-Info: i220505202449:72f0526e73a3b5be,v Content-Language: en Set-Cookie: cfid=27df784a-93ac-43e1-b12f-d3d36474853d;Path=/;Expires=Fri, 27-May-2022 10:37:52 UTC;HTTPOnly Set-Cookie: cftoken=0;Path=/;Expires=Fri, 27-May-2022 10:37:52 UTC;HTTPOnly Set-Cookie: SAMESITE=Lax;Path=/ Set-Cookie: JSESSIONID=DC675D313077F1D60C6B644B2051A173;path=/;HttpOnly X-Powered-By: Innovasium/iCMS-Ramsay1 X-Powered-By-Type: Live |
interfacebiologics.com Whois Information
Domain Name: INTERFACEBIOLOGICS.COM Registry Domain ID: 80279225_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.wildwestdomains.com Registrar URL: http://www.wildwestdomains.com Updated Date: 2021-11-16T14:31:33Z Creation Date: 2001-11-26T17:01:49Z Registry Expiry Date: 2022-11-26T17:01:49Z Registrar: Wild West Domains, LLC Registrar IANA ID: 440 Registrar Abuse Contact Email: abuse@wildwestdomains.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS53.DOMAINCONTROL.COM Name Server: NS54.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-07T09:47:17Z <<< |